Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/26/2012WO2012112007A3 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
10/26/2012WO2012108650A3 Uses of a monoclonal antibody to proteinase-3 as a therapeutic agent or as a diagnostic agent for a stroke
10/26/2012WO2012104550A3 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER
10/26/2012WO2012075242A3 Controlled chemical release of hydrogen sulfide
10/26/2012WO2007042166A8 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
10/26/2012CA2833698A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
10/26/2012CA2833547A1 Methods and compositions suitable for preventing and treating hyperleptinemia
10/26/2012CA2832992A1 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
10/26/2012CA2832343A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/26/2012CA2831164A1 Infant formula for use in the prevention of cardiovascular diseases
10/25/2012US20120270955 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/25/2012US20120270934 Prostacyclin derivatives
10/25/2012US20120270929 Modulation of ttc39 expression to increase hdl
10/25/2012US20120270922 Antiangiogenic Agent and Method for Inhibition of Angiogenesis
10/25/2012US20120270912 Substituted Indolealkanoic Acids
10/25/2012US20120270907 Therapeutic uses of nicotine
10/25/2012US20120270901 Indene derivatives as pharmaceutical agents
10/25/2012US20120270899 Compositions and Methods for Treating Cardiovascular Diseases
10/25/2012US20120270884 Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270850 Metal delivery agents and therapeutic uses of the same
10/25/2012US20120270846 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270827 Indole Antiviral Compositions And Methods
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270793 Methods of treating a patient receiving a cardiac stent implant
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270790 Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with annexin a1 short peptide
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270771 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270769 Methods of using macrocyclic inhibitors of serine protease enzymes
10/25/2012US20120269898 Compositions and methods of treating pulmonary hypertension
10/25/2012US20120269881 Transdermal drug delivery device including an occlusive backing
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269836 Vaccine
10/25/2012US20120269834 Immunoglobulin cleavage fragment vaccine compositions
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269810 Methods and compositions for panic disorders
10/25/2012US20120269806 Methods of inducing tolerance
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269790 Use of plant extracts as prebiotics, compositions and foods containing such extract
10/25/2012US20120269787 Systemic, allogenic stem cell therapies for treatment of diseases in equines
10/25/2012US20120269786 Systemic, allogenic stem cell therapies for treatment of diseases in felines
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269784 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/25/2012US20120269783 Composition containing autologous mononuclear cells and pig collagen scaffold in paste form and its use in the preparation of a medicament for surgical treatment
10/25/2012US20120269775 Adipose Stromal Stem Cells For Tissue And Vascular Modification
10/25/2012US20120269733 Model Systems and Treatment Regimes for Treatment of Neurological Disease
10/25/2012DE102011007891A1 New ring-fused 4-aminopyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease and renal insufficiency
10/25/2012DE102011007890A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
10/24/2012EP2514752A1 Epothilone compounds, preparation method and use thereof
10/24/2012EP2514749A1 Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012EP2514739A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
10/24/2012EP2514435A1 Infant formula for use in the prevention of cardiovascular diseases
10/24/2012EP2514432A1 Sea cucumber compound preparation and preparation method thereof
10/24/2012EP2514431A1 A sea cucumber compound product, preparation method and preparation forms thereof
10/24/2012EP2514421A1 Composition comprising torasemide
10/24/2012EP2514418A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof
10/24/2012EP2513307A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2513101A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
10/24/2012EP2513100A1 New phenylhydrazone derivatives and their use as pharmaceuticals
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513066A1 Sphingosine kinase inhibitors
10/24/2012EP2512479A1 Methods and compositions for treating peripheral vascular disease
10/24/2012CN102753545A Oxadiazole derivative having endothelial lipase inhibitory activity
10/24/2012CN102753544A 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/24/2012CN102753530A Benzazepine compound
10/24/2012CN102753520A N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
10/24/2012CN102753519A Bis-acylated hydroxylamine derivatives
10/24/2012CN102753182A Concentrated therapeutic phospholipid compositions
10/24/2012CN102753167A New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases
10/24/2012CN102746401A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/24/2012CN102746400A Antibodies against human angiopoietin 2
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102746280A Pyrimidone compound and preparation method thereof
10/24/2012CN102746220A Novel pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids
10/24/2012CN102746214A Novel indoline compounds
10/24/2012CN102743755A Composition and method for preventing recurrence of stroke
10/24/2012CN102743744A Applications of alliinase, and medicinal composition
10/24/2012CN102743734A Application of Tianlou Guizhi decoction in treatment of post-stroke spasm
10/24/2012CN102743709A Traditional Chinese medicine preparation for treating wind-evil invasion supraorbital neuralgia and preparation method thereof
10/24/2012CN102743708A Cordyceps sinensis and gecko powder for treating emphysema pulmonary heart disease asthma chronic bronchitis
10/24/2012CN102743598A var. Denneanum extract and formula particles thereof
10/24/2012CN102743583A Chinese patent medicine and traditional Chinese medicine decoction capable of effectively treating coronary heart disease
10/24/2012CN102743581A Diabetes mellitus traditional Chinese medicine foot bath prescription
10/24/2012CN102743578A Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction
10/24/2012CN102743539A Traditional Chinese medicine for treating coronary heart disease with warming yang and promoting blood circulation effects, and preparation method for same
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 1595